gregory fahy californiabased cryobiologist biogerontologist businessman vice president chief scientific officer twentyfirst century medicine inc cofounded intervene immune company developing clinical methods reverse immune system president society native california fahy holds bachelor science degree biology university california irvine phd pharmacology cryobiology medical college georgia currently serves board directors two organizationswhich referee numerous scientific journals funding agencies holds patents cryopreservation methods aging interventions transplantation topicscitation needed fahy worlds foremost expert organ cryopreservation fahy introduced modern successful approach vitrification cryopreservation widely credited along william f rall introducing vitrification field reproductive keynote speaker annual society cryobiology meeting fahy announced twentyfirst century medicine successfully cryopreserved rabbit kidney vitrification transplanted rabbit rewarming subsequent longterm life support vitrifiedrewarmed kidney sole kidney research breakthrough later published peerreviewed journal fahy also biogerontologist originator editorinchief future aging pathways human life extension multiauthored book future currently serves editorial boards rejuvenation research open geriatric medicine journal served years director american aging association years editor age news organizations newsletter scientist american red cross fahy originator first practical method cryopreservation vitrification inventor computerbased systems apply technology whole organs joining twentyfirst century medicine chief scientist organ inc lrt inc also head tissue cryopreservation section transfusion cryopreservation research program us naval medical research institute bethesda maryland spearheaded original concept ice blocking agents named fellow society cryobiology recognition impact work low temperature fahy led triim thymus regeneration immunorestoration insulin mitigation human clinical trial designed reverse aspects human aging purpose triim trial investigate possibility using recombinant human growth hormone rhgh prevent reverse signs immunosenescence ten putatively healthy men study observed protective immunological changes improved risk indices many diseases mean epigenetic age approximately years less baseline year treatment change compared treatment end fahy named fellow society cryobiology received distinguished scientist award reproductive biology reproductive biology professional group american society reproductive medicinecitation needed received cryopreservation award international longevity cryopreservation summit held madrid spain recognition career dedication field cryobiology fahy also received grand prize medicine inpex invention computerized organ cryoprotectant perfusion technology recognized fellow american aging associationcitation needed httpsenwikipediaorgwikigregfahy